Janet Lightner

481 total citations
19 papers, 317 citations indexed

About

Janet Lightner is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Janet Lightner has authored 19 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Janet Lightner's work include Cancer, Lipids, and Metabolism (8 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Janet Lightner is often cited by papers focused on Cancer, Lipids, and Metabolism (8 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Janet Lightner collaborates with scholars based in United States, Japan and Colombia. Janet Lightner's co-authors include Koyamangalath Krishnan, William L. Stone, Victoria Palau, Michael F. Wempe, Peter J. Rice, Sharon Campbell, Shrikanth A.G. Reddy, Shin Wakui, Naohiko Anzai and Hitoshi Endou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Janet Lightner

18 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Lightner United States 9 170 71 62 56 51 19 317
Ankur Karmokar United Kingdom 9 306 1.8× 137 1.9× 69 1.1× 19 0.3× 76 1.5× 15 640
Rakesh Dachineni United States 10 138 0.8× 50 0.7× 14 0.2× 23 0.4× 72 1.4× 13 363
Takayuki Kumano Japan 10 178 1.0× 69 1.0× 24 0.4× 28 0.5× 22 0.4× 16 456
Hongsong Yang United States 10 130 0.8× 28 0.4× 86 1.4× 43 0.8× 34 0.7× 13 353
Jesmin Mondal India 11 140 0.8× 43 0.6× 39 0.6× 11 0.2× 28 0.5× 12 368
Mohamed O. Mahmoud Egypt 13 200 1.2× 55 0.8× 15 0.2× 13 0.2× 86 1.7× 24 575
Yasmeen M. Attia Egypt 13 173 1.0× 103 1.5× 25 0.4× 10 0.2× 49 1.0× 25 432
Zhou Yingfeng China 10 295 1.7× 98 1.4× 65 1.0× 8 0.1× 108 2.1× 11 527
Smiti Gupta United States 16 391 2.3× 74 1.0× 81 1.3× 35 0.6× 138 2.7× 37 658
Joseph E. Ocando United States 7 265 1.6× 26 0.4× 69 1.1× 24 0.4× 162 3.2× 7 425

Countries citing papers authored by Janet Lightner

Since Specialization
Citations

This map shows the geographic impact of Janet Lightner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Lightner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Lightner more than expected).

Fields of papers citing papers by Janet Lightner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Lightner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Lightner. The network helps show where Janet Lightner may publish in the future.

Co-authorship network of co-authors of Janet Lightner

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Lightner. A scholar is included among the top collaborators of Janet Lightner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Lightner. Janet Lightner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jutabha, Promsuk, Vijay Kumar, Naohiko Anzai, et al.. (2025). Benzbromarone Analog SAR: Potent hURAT1 (SLC22A12) Inhibitors and Drug Transporter Interaction Studies. Drug Design Development and Therapy. Volume 19. 1377–1392. 2 indexed citations
2.
Wang, Ling, Juan Zhao, Madison Schank, et al.. (2024). Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV. SHILAP Revista de lepidopterología. 5. 1414866–1414866. 3 indexed citations
5.
Moore, Christine, et al.. (2018). Abstract 3977: γ-Tocotrienol and metformin are cytotoxic to prostate cancer cell lines and exhibit synergy. Cancer Research. 78(13_Supplement). 3977–3977.
7.
Moore, Christine, et al.. (2017). Precision prostate cancer chemoprevention with gamma-tocotrienol.. Journal of Clinical Oncology. 35(15_suppl). e13043–e13043. 1 indexed citations
9.
Stone, William L., et al.. (2016). AKT1 Activation Up Regulates Peroxiredoxin 1 in Human Melanoma Cells. Free Radical Biology and Medicine. 100. S130–S130. 2 indexed citations
10.
Niyazi, Maximilian, et al.. (2015). Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate.. PubMed. 35(4). 1851–9. 11 indexed citations
11.
Palau, Victoria, et al.. (2013). Gamma-Tocotrienol and Simvastatin Synergistically Induce Cytotoxicity In Leukemia Cell Lines, K-562 and HL-60. Blood. 122(21). 4927–4927. 1 indexed citations
12.
Wempe, Michael F., Janet Lightner, Bettina Miller, et al.. (2012). Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies. Drug Design Development and Therapy. 6. 323–323. 10 indexed citations
13.
Jiang, Yu, Deling Yin, Jing Zhao, et al.. (2012). A specific molecular beacon probe for the detection of human prostate cancer cells. Bioorganic & Medicinal Chemistry Letters. 22(11). 3632–3638. 5 indexed citations
14.
Wood, Robert C., Rubén Torrenegra, Sam Harirforoosh, et al.. (2012). Anti-Neoplastic Activity of Two Flavone Isomers Derived from Gnaphalium elegans and Achyrocline bogotensis. PLoS ONE. 7(6). e39806–e39806. 25 indexed citations
15.
Palau, Victoria, Janet Lightner, William L. Stone, et al.. (2011). Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radical Biology and Medicine. 51(6). 1164–1174. 70 indexed citations
16.
Campbell, Sharon, Sarah Whaley, Julie B. Stimmel, et al.. (2011). γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer. Free Radical Biology and Medicine. 50(10). 1344–1354. 33 indexed citations
17.
Wempe, Michael F., Peter J. Rice, Janet Lightner, et al.. (2011). Metabolism and Pharmacokinetic Studies of JPH203, an L-Amino Acid Transporter 1 (LAT1) Selective Compound. Drug Metabolism and Pharmacokinetics. 27(1). 155–161. 58 indexed citations
18.
Wempe, Michael F., et al.. (2009). Investigating idebenone and idebenone linoleate metabolism: in vitro pig ear and mouse melanocyte studies. Journal of Cosmetic Dermatology. 8(1). 63–73. 8 indexed citations
19.
Wempe, Michael F., Charles B. Wright, James L. Little, et al.. (2008). Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS. International Journal of Pharmaceutics. 370(1-2). 93–102. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026